The FDA’s verdict on Poherdy comes amid Perjeta creator Genentech’s patent infringement lawsuit against Organon and Shanghai ...

A CHMP panel has recommended the high-dose version’s approval, countering an FDA rejection for the drug in recent months.

Medicxi will use the €500m kitty to continue supporting drug hunters and entrepreneurs in creating asset-focused ...

The fund will participate in follow-on and initial rounds, focusing on biotech and medtech ventures across core markets.

Sarepta has received US FDA approval for updated prescribing information for Elevidys, an AAV-based gene transfer therapy.